As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.
AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes.
The affiliated companies of Community Care of North Carolina, along with GlaxoSmithKline and the UNC Eshelman School of Pharmacy, on Thursday announced their intent to develop, implement and test new approaches to care delivery.
Dr. Reddy's Labs on Tuesday announced the launch of sirolimus tablets in 1-mg and 2-mg dosage strengths.
The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.
he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A.
From Oct. 27 through Nov. 1, 2014, more than 11,000 McKesson employees at more than 170 locations across the United States will participate in the 16th Community Days program.
Novartis announced that it has entered into a definitive agreement to divest its influenza vaccines business to CSL for an agreed price of $275 million.
Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.
Burmans, an independent community pharmacy, was announced as a winner of the Patient Safety Award at the annual Innovation Awards presented by Philadelphia Business Journal and UnitedHealthcare.